Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (10) , 1773-1777
- https://doi.org/10.1016/0006-2952(85)90648-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Chemotherapeutic implications of polyamine biosynthesis inhibitionClinical Pharmacology & Therapeutics, 1984
- .alpha.-(Fluoromethyl)dehydroornithine and .alpha.-(fluoromethyl)dehydroputrescine analogs as irreversible inhibitors of ornithine decarboxylaseJournal of Medicinal Chemistry, 1983
- In vivo effects of α-dl-Difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei bruceiMolecular and Biochemical Parasitology, 1983
- α-monofluoromethyl and α-difluoromethyl putrescine as ornithine decarboxylase inhibitors: In vitro and in vivo biochemical propertiesBiochemical Pharmacology, 1982
- Restriction of bacterial growth by inhibition of polyamine biosynthesis by using monofluoromethylornithine, difluoromethylarginine and dicyclohexylammonium sulphateBiochemical Journal, 1982
- Polyamine metabolism and functionAmerican Journal of Physiology-Cell Physiology, 1982
- DL-α-Monofluoromethylputrescine is a potent irreversible inhibitor of Escherichia coli ornithine decarboxylaseBiochemical Journal, 1982
- Polyamine Metabolism: A Potential Therapeutic Target in TrypanosomesScience, 1980
- Selective inhibitors of biosynthesis of aminergic neurotransmittersNature, 1978
- Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogsJournal of the American Chemical Society, 1978